Revvity, Inc. updated earnings guidance For the full year 2024. For the year, the Company is updating its full year 2024 total revenue guidance to a range of $2.76 - $2.82 billion to reflect recent changes in foreign currency exchange rates.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
113.2 USD | +1.08% | +6.29% | +3.59% |
May. 14 | Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM | |
Apr. 30 | TD Cowen Adjusts Price Target on Revvity to $130 From $123 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.59% | 13.97B | |
+11.18% | 225B | |
+15.22% | 197B | |
+19.19% | 143B | |
+30.89% | 111B | |
+2.66% | 64.72B | |
+18.48% | 54.44B | |
+5.12% | 51.06B | |
+10.53% | 45.03B | |
+5.98% | 37.4B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Revvity, Inc. Updates Earnings Guidance for the Full Year 2024